Clinical Trial Details

EORTC-1202-STBSG

Back to Clinical Trials Database

Phase II trial of cabazitaxel in metastatic or inoperable locally advanced dedifferentiated liposarcoma.

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 07-Aug-2014
Date Step1 close: 22-Mar-2019
Date Step2 close: 22-Mar-2019
Data management at EORTC Yes
Design Phase 2
Not randomized / N.A.
Targeted Sample size EORTC Groups: 50 - All Groups: 50
Treatment Drug
Cabazitaxel
Study Staff Richard L. Hayward (Study Coordinator) , NHS Lothian - Western General Hospital, Edinburgh
Saskia Litiere (Statistician) , EORTC Headquarters, Brussels
Hafida Lmalem (Data Manager) , EORTC Headquarters, Brussels
Jammbe Musoro (Statistician) , EORTC Headquarters, Brussels
Sandrine Rivrain (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Ionela Stanciu (Clinical Operations Manager) , EORTC Headquarters, Brussels
Leen Wijnen (Data Manager) , EORTC Headquarters, Brussels
Xiao Mang Zhou (Junior RAM) , EORTC Headquarters, Brussels
Type of cancer Soft Tissue and Bone Sarcoma
Participating groups EORTC Soft Tissue and Bone Sarcoma Group
Recruiting centers Centre Georges-Francois-Leclerc (DIJON CEDEX, France)
Centre Leon Berard (Lyon, France)
Clatterbridge Cancer Center - Wirral (Wirral, United Kingdom)
Hopital de La Timone (APHM) (MARSEILLE CEDEX 5, France)
IRCCS - Fondazione Istituto Nazionale dei Tumori (Milano, Italy)
IRCCS - Istituto Oncologico Veneto (Padova, Italy)
Institut Jules Bordet (Anderlecht, Belgium)
Leiden University Medical Centre (Leiden, Netherlands)
NHS Lothian - Western General Hospital (Edinburgh, United Kingdom)
Radboud University Medical Center Nijmegen (Nijmegen, Netherlands)
Royal Marsden Hospital - Chelsea, London (London, United Kingdom)
The Christie NHS Foundation Trust (Manchester, United Kingdom)
The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, Netherlands)
Universitair Ziekenhuis Antwerpen (Edegem, Belgium)
Protocol summary http://clinicaltrials.gov/study/NCT01913652
NCT number NCT01913652
EudraCT 2012-003672-39
Financial Support Educational Grant
EORTC Group